Increlex - supply shortage
Resolved
mecasermin
ShortageHuman
Shortage information
The shortage affecting Increlex has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Increlex
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- mecasermin
- Therapeutic area (MESH)
- Laron Syndrome
- Pharmaceutical forms affected
- Solution for subcutaneous injection
- Strengths affected
- 10 mg/ml
- Availability of alternatives
- No
Key dates
- First published